Received: 26 May 2021
Accepted: 24 August 2021
First Online: 1 September 2021
: The SMO platform received approval from the French national commission for data privacy (<i>Commission Nationale Informatique et Libertés</i>, CNIL) and patients provided informed consent that their anonymous data may be used for research and quality improvement purposes. No additional approvals were required according to the French legislation as it was an observational study based on medical records. All methods were performed in accordance with the relevant guidelines and regulations (Declarations of Helsinki).
: Not applicable.
: Isabelle Adamowicz, Philippe Denormandie, Pierre Denys, and Laurent Degos are non-remunerated scientific board member of the SMO platform evaluated in this study.